SCHEMBL5859907

SCHEMBL5859907

COC1=C(OC)C(=O)C(c2cc(C)c(-c3cccc(OC)c3)c(C(=O)N3CCOCC3)c2)=C(C)C1=O

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
RAB9A P51151 5/20 0.49
NPC1 O15118 3/20 0.49
L3MBTL1 Q9Y468 2/20 0.49
JAK2 O60674 2/20 0.46
JAK1 P23458 2/20 0.46
TYK2 P29597 2/20 0.46
JAK3 P52333 2/20 0.46
BTK Q06187 1/20 0.46
MEN1 O00255 1/20 0.45
KMT2A Q03164 1/20 0.45
ALDH1A1 P00352 6/20 0.45
KDM4E B2RXH2 4/20 0.45
HPGD P15428 3/20 0.45
CNR1 P21554 1/20 0.44
CNR2 P34972 1/20 0.44
PLAUR Q03405 1/20 0.43
PTGS2 P35354 1/20 0.43
NR1H2 P55055 1/20 0.42
NR1H3 Q13133 1/20 0.42
SMN1; SMN2 Q16637 2/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5859916 0.91 RAB9A (0.49) RAB9ANPC1L3MBTL1JAK2BTK
SCHEMBL6661310 0.91 ALDH1A1 (0.47) RAB9ANPC1ALDH1A1KDM4EHPGD
SCHEMBL5862104 0.91 PLAUR (0.44) RAB9AMEN1KMT2AALDH1A1KDM4E
SCHEMBL5859258 0.86 ALDH1A1 (0.40) RAB9ANPC1L3MBTL1JAK2JAK1
SCHEMBL5859257 0.85 HTT (0.45) RAB9ANPC1JAK2JAK1TYK2
SCHEMBL5858845 0.82 GPR35 (0.47) ALDH1A1KDM4EHPGD
SCHEMBL5859859 0.81 TDP1 (0.46) RAB9ANPC1ALDH1A1KDM4EHPGD
SCHEMBL5859929 0.81 TDP1 (0.41) RAB9ANPC1SMN1; SMN2HTT
SCHEMBL7065086 0.76 ALDH1A1 (0.46) RAB9ANPC1JAK2JAK1TYK2
SCHEMBL5862246 0.76 CYP2C9 (0.41) RAB9AMEN1KMT2AALDH1A1KDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7122543-B2 Substituted benzoic acid derivatives having NF-κB inhibiting action DAIICHI SUNTORY PHARMA CO., LTD. (JP) 2006-10-17 US disclosed
EP-1437339-A1 SUBSTITUTED BENZOIC ACID DERIVATIVES EXHIBITING NF-KAPPA B INHIBITING ACTIVITY Daiichi Suntory Pharma Co., Ltd. (JP) 2004-07-14 EP disclosed